Advances in microfluidic extracellular vesicle technology
Advances in Clinical Chemistry · 2026
DOI: 10.1016/bs.acc.2026.03.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2026. Verfasst von M Eigenfeld und 1 weiteren Autor:innen. Beteiligte Einrichtung: NanoLab, Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria; BioTechMed-Graz, 8010 Graz, Aus…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Microfluidic Analytical Techniques, Microfluidics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben.
Abstract (Originalsprache)
Extracellular vesicles (EV) have emerged as vital biological entities, playing significant roles in intercellular communication, disease progression, and therapeutic interventions. However, conventional EV isolation methods, including ultracentrifugation, precipitation, and chromatography, present limitations such as low purity, prolonged processing times, high sample volume requirements, and inconsistent reproducibility, hindering their clinical adoption. Recent developments in microfluidic technologies have demonstrated substantial potential to overcome these challenges by offering precise, rapid, scalable, and high-throughput EV isolation with improved purity and specificity. This chapter critically evaluates the current state of EV research in clinical chemistry, emphasizing their diagnostic and therapeutic utility in oncology, neurodegenerative diseases, and personalized medicine. The chapter highlights the transformative role of microfluidic platforms that leverage size-, density-, and immunoaffinity-based approaches, coupled with advanced integration capabilities for downstream analyses. Furthermore, the scalability, standardization, regulatory considerations, and practical integration of these innovative technologies into clinical practice are thoroughly examined. Although technical, economic, and regulatory challenges persist, ongoing collaborative standardization efforts and continued technological advancements position microfluidic-based EV isolation as a pivotal approach for precision diagnostics and targeted therapeutics, ultimately enhancing patient outcomes and healthcare efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NanoLab, Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria; BioTechMed-Graz, 8010 Graz, Austria. Electronic address: marco.eigenfeld@medunigraz.at.
- NanoLab, Division of Medicinal Chemistry, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria; BioTechMed-Graz, 8010 Graz, Austria. Electronic address: sebastian.schwaminger@medunigraz.at.
Zitieren
APA
Eigenfeld, M., & Schwaminger, S. P. (2026). Advances in microfluidic extracellular vesicle technology. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2026.03.004
Vancouver
Eigenfeld M, Schwaminger SP. Advances in microfluidic extracellular vesicle technology. Advances in Clinical Chemistry. 2026. doi:10.1016/bs.acc.2026.03.004
BibTeX
@article{Eigenfeld2026,
author = {Eigenfeld, M and Schwaminger, S P},
title = {Advances in microfluidic extracellular vesicle technology},
journal = {Advances in Clinical Chemistry},
year = {2026},
doi = {10.1016/bs.acc.2026.03.004}
}
EUVIMED